ReviewPharmacoEconomics2006

Pharmacoeconomics of angiotensin II antagonists in type 2 diabetic patients with nephropathy: implications for decision making.

Cornelis Boersma et al.PubMed ↗Publisher ↗

No numbers read from the abstract.